Cargando…

Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

BACKGROUND: Growing evidence has indicated that tumor biomarkers, including cytokeratin 19 fragment antigen 21–1 (Cyfra21–1), carbohydrate antigen 19–9 (CA19–9), carbohydrate antigen 72–4 (CA72–4), carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCC-Ag) were reported to be common...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yuchong, Huang, Xuanzhang, Zhou, Likun, Deng, Ting, Ning, Tao, Liu, Rui, Zhang, Le, Bai, Ming, Zhang, Haiyang, Li, Hongli, Ba, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544972/ https://www.ncbi.nlm.nih.gov/pubmed/31151431 http://dx.doi.org/10.1186/s12885-019-5755-5

Ejemplares similares

Sintilimab Plus Apatinib and Chemotherapy as Second‑/Third-Line treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a prospective, Single-Arm, phase II trial
por: Zhang, Le, et al.
Publicado: (2023)

The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma
por: Liu, Rui, et al.
Publicado: (2015)

Effects of miR-138-5p and miR-204-5p on the migration and proliferation of gastric cancer cells by targeting EGFR
por: Wang, Yi, et al.
Publicado: (2018)

Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis
por: Yang, Haiou, et al.
Publicado: (2020)

Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis: Erratum
por: Yang, Haiou, et al.
Publicado: (2022)

miR-370 regulates cell proliferation and migration by targeting EGFR in gastric cancer
por: Ning, Tao, et al.
Publicado: (2022)

Third-line treatment patterns and clinical outcomes for metastatic colorectal cancer: a retrospective real-world study
por: Deng, Ting, et al.
Publicado: (2023)

MiR-17-5p regulates cell proliferation and migration by targeting transforming growth factor-β receptor 2 in gastric cancer
por: Qu, Yanjun, et al.
Publicado: (2016)

Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis
por: Zhang, Haiyang, et al.
Publicado: (2017)

Author Correction: Exosome-delivered EGFR regulates liver microenvironment to promote gastric cancer liver metastasis
por: Zhang, Haiyang, et al.
Publicado: (2023)

Efficacy and survival of anti-PD-1 antibody in combination with trastuzumab and chemotherapy versus trastuzumab and chemotherapy as first-line treatment of HER2-positive metastasis gastric adenocarcinoma: a retrospective study
por: Deng, Ting, et al.
Publicado: (2023)

CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
por: Zhang, Haiyang, et al.
Publicado: (2020)

Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial
por: Zhou, Likun, et al.
Publicado: (2021)

The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer
por: Yang, Yuchong, et al.
Publicado: (2023)

Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma
por: Yang, Hong, et al.
Publicado: (2015)

Onco-miR-130 promotes cell proliferation and migration by targeting TGFβR2 in gastric cancer
por: Duan, Jingjing, et al.
Publicado: (2016)

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
por: Lin, Dan, et al.
Publicado: (2021)

Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma
por: Zhuge, Lingdun, et al.
Publicado: (2020)

Serum microRNAs as Biomarkers for the Noninvasive Early Diagnosis of Biliary Tract Cancer
por: Han, Yueting, et al.
Publicado: (2021)

Study on chemotherapeutic sensitizing effect of nimotuzumab on different human esophageal squamous carcinoma cells
por: YANG, XIAOYU, et al.
Publicado: (2016)

Exosomal miR-208b related with oxaliplatin resistance promotes Treg expansion in colorectal cancer
por: Ning, Tao, et al.
Publicado: (2021)

Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
por: Bai, Ming, et al.
Publicado: (2022)

Exosomes Carrying MicroRNA-155 Target Forkhead Box O3 of Endothelial Cells and Promote Angiogenesis in Gastric Cancer
por: Zhou, Zhengyang, et al.
Publicado: (2019)

Retraction Notice to: Exosomes Carrying MicroRNA-155 Target Forkhead Box O3 of Endothelial Cells and Promote Angiogenesis in Gastric Cancer
por: Zhou, Zhengyang, et al.
Publicado: (2022)

Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C/EPBβ
por: Liu, Ying, et al.
Publicado: (2022)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Adipocyte‐Derived Exosomal MTTP Suppresses Ferroptosis and Promotes Chemoresistance in Colorectal Cancer
por: Zhang, Qiumo, et al.
Publicado: (2022)

High Expression of GOLPH3 in Esophageal Squamous Cell Carcinoma Correlates with Poor Prognosis
por: Wang, Jian-Hua, et al.
Publicado: (2012)

RAP80 is an independent prognosis biomarker for the outcome of patients with esophageal squamous cell carcinoma
por: Yang, Qingyuan, et al.
Publicado: (2018)

The Role of DBR1 as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2022)

Upregulation of Centromere Proteins as Potential Biomarkers for Esophageal Squamous Cell Carcinoma Diagnosis and Prognosis
por: Wang, Xiao, et al.
Publicado: (2022)

Interleukin-8 and Interleukin-6 Are Biomarkers of Poor Prognosis in Esophageal Squamous Cell Carcinoma
por: Pastrez, Paula Roberta Aguiar, et al.
Publicado: (2023)

Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation
por: Ng, Hoi Yan, et al.
Publicado: (2018)

Suppressor PAQR3 associated with the clinical significance and prognosis in esophageal squamous cell carcinoma
por: Bai, Ge, et al.
Publicado: (2018)

Esophageal squamous cell carcinoma and prognosis in Taiwan
por: Cheng, Ya‐Fu, et al.
Publicado: (2018)

Onco-miR-24 regulates cell growth and apoptosis by targeting BCL2L11 in gastric cancer
por: Zhang, Haiyang, et al.
Publicado: (2016)

Exosome miR-155 Derived from Gastric Carcinoma Promotes Angiogenesis by Targeting the c-MYB/VEGF Axis of Endothelial Cells
por: Deng, Ting, et al.
Publicado: (2020)

Retraction Notice to: Exosome miR-155 Derived from Gastric Carcinoma Promotes Angiogenesis by Targeting the c-MYB/VEGF Axis of Endothelial Cells
por: Deng, Ting, et al.
Publicado: (2022)

A Panel of Overexpressed Proteins for Prognosis in Esophageal Squamous Cell Carcinoma
por: Shang, Li, et al.
Publicado: (2014)

RBBP7 is a prognostic biomarker in patients with esophageal squamous cell carcinoma
por: Yu, Ning, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c83r320jedm2nqm66313hqgaqn